BSTC Financial Facts

Licensing revenues: 2.02M
Research and development: 372.73K
See Full Income Statement

Deferred tax assets -long term: -2.98M
Deferred tax assets: 94.99K
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +51.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A +31.2% Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A +29.4% Details
11/8/11 Q311 $0.04N/A N/A $1.9M$1M N/A +46.3% Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A -7.7% Details